Johnson & Johnson and BARDA together commit more than $1 billion to novel Coronavirus vaccine research and development; company expects to initiate phase 1 human clinical studies of vaccine candidate at latest by September 2020.
(Source: Johnson & Johnson)
AIM (Association des Industries de Marque) is the European Brands Association, which represents manufacturers of branded consumer goods in Europe on key issues that affect their ability to design, distribute and market their brands. AIM’s membership comprises 2,500 businesses ranging from SMEs to multinationals, directly or indirectly through its corporate and national association members.
